SI
IMNM icon

Scharf Investments’s Immunome IMNM Stock Holding History

Scharf Investments’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$941K Hold
44,389
– – 0.03% 58
2026
Q1 		$971K Hold
44,389
– – 0.03% 57
2025
Q4 		$953K Hold
44,389
– – 0.03% 57
2025
Q3 		$520K Hold
44,389
– – 0.01% 62
2025
Q2 		$413K Hold
44,389
– – 0.01% 56
2025
Q1 		$299K Hold
44,389
– – 0.01% 56
2024
Q4 		$471K Buy
+44,389
New +$536K 0.01% 54

Other funds holding IMNM

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Scharf Investments's IMNM Position: Q2 2026 in Review

Scharf Investments held its Immunome (IMNM) position steady in Q2 2026 at 44,389 shares worth $941K. The position accounts for 0.03% of the portfolio, ranked #58.

Scharf Investments first reported a position in IMNM in Q4 2024 and has held it in 7 quarters since. The position peaked at $971K in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Scharf Investments held 44,389 shares of Immunome worth $941K as of Q2 2026.
  • Scharf Investments left its Immunome share count unchanged in Q2 2026.
  • Immunome made up 0.03% of Scharf Investments's portfolio in Q2 2026, its #58 holding.
  • Scharf Investments first reported a position in Immunome in Q4 2024 and has held it in 7 quarters since.
  • Scharf Investments's Immunome position peaked at $971K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Scharf Investments's 13F filing for Q2 2026, filed 13 Jul 2026.